Propanc Biopharma Maximum Drawdown
| PPCB Stock | | | USD 0.11 -0.01 -8.33% |
Historical market data for Propanc Biopharma Common forms the basis of the Maximum Drawdown indicator shown here. The calculation draws on time-series market data across available periods. Propanc Biopharma has a market cap of 1.76 M. See
Your Equity Center for portfolio-level analysis. Propanc Biopharma Common can be included in a portfolio to evaluate diversification impact. This information is provided for contextual purposes. Broader economic conditions can influence Propanc Biopharma Common's company valuation — related indicators include
signals in discontinued.
Propanc Biopharma Common has current Maximum Drawdown of 58.21. Maximum Drawdown (or MDD) is another indicator of risk. It is the reduction in asset value after a series of losing trades. This is normally calculated by getting the difference between a relative peaks in equity capital minus a relative trough.
Maximum Drawdown | = | MAX(HIGH - LOW) |
| = | 58.21 | |
| MAX | = | Maximum notation for the range of returns on Propanc Biopharma |
Maximum Drawdown Peers Comparison
Maximum Drawdown Relative To Other Indicators
Propanc Biopharma Common is rated
below average in maximum drawdown among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
1.00 of Maximum Drawdown per Maximum Drawdown.
The MDD is one of the most important risk measures. It measures the loss in any losing period and is usually defined as the percent retrenchment from an asset peak value to the valley value. Maximum drawdown encompasses both the period from the peak to the valley (length), and the time from the valley to a new high (recovery). It measures the largest percentage drawdown that has occurred in a given time period.
Compare Propanc Biopharma to Peers
Other Technical Indicators